Arrowhead Pharmaceuticals (ARWR) Revenue (2010 - 2026)
Arrowhead Pharmaceuticals' (ARWR) quarterly Revenue came in at $73.7 million in Q1 2026, down 86.41% YoY from $542.7 million in Q1 2025, and down 72.07% on a QoQ basis from $264.0 million in Q4 2025.
Arrowhead Pharmaceuticals (ARWR) Revenue (2010 - 2026) Analysis & Trends
Arrowhead Pharmaceuticals (ARWR) has 17 years of Revenue data on file, last reported at $73.7 million in Q1 2026.
- Quarterly Revenue fell 86.41% year-over-year to $73.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $622.0 million (up 14.09% YoY) and the FY2025 annual result came in at $829.4 million, up 23258.15% from the prior year.
- Revenue declined to $73.7 million in Q1 2026, from $264.0 million in the prior quarter.
- In the past five years, Revenue ranged from a high of $542.7 million in Q1 2025 to a low of $2.5 million in Q4 2024.
- A 5-year average of $116.2 million and a median of $47.5 million in 2022 frame the typical range for Revenue.
- Annual changes were most pronounced in 2023 — Revenue tumbled 94.32% — and 2025, when it jumped 10461.32%.
- Tracing ARWR's Revenue over 5 years: stood at $62.5 million in 2022, then plunged by 94.32% to $3.6 million in 2023, then decreased by 29.6% to $2.5 million in 2024, then jumped by 10461.32% to $264.0 million in 2025, then sank by 72.07% to $73.7 million in 2026.
- The last three Revenue figures came in at $73.7 million (Q1 2026), $264.0 million (Q4 2025), and $256.5 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.56 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.71 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3,001.92 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 674.14 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.29 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 425.49 Mn |
| 10 | Arrowhead Pharmaceuticals | 12.23 Bn | 10.63 Bn | - | 75.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 75.25 Mn |
| Mar 31, 2026 | 73.74 Mn |
| Dec 31, 2025 | 264.03 Mn |
| Sep 30, 2025 | 256.47 Mn |
| Jun 30, 2025 | 27.77 Mn |
| Mar 31, 2025 | 542.71 Mn |
| Dec 31, 2024 | 2.50 Mn |
| Dec 31, 2023 | 3.55 Mn |
| Sep 30, 2023 | 16.10 Mn |
| Jun 30, 2023 | 15.83 Mn |
| Mar 31, 2023 | 146.27 Mn |
| Dec 31, 2022 | 62.55 Mn |
| Sep 30, 2022 | 31.58 Mn |
| Jun 30, 2022 | 32.41 Mn |
| Mar 31, 2022 | 151.81 Mn |
| Dec 31, 2021 | 27.44 Mn |
| Sep 30, 2021 | 38.28 Mn |
| Jun 30, 2021 | 45.89 Mn |
| Mar 31, 2021 | 32.81 Mn |
| Dec 31, 2020 | 21.30 Mn |